Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.41 |
| ▸ | FPR1 | P21462 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8605204 | 0.87 | TP53 (0.47) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| SCHEMBL25867914 | 0.85 | TP53 (0.40) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Diethylamine SCHEMBL27873528 | 0.83 | TP53 (0.35) | TP53SLC7A5FPR1FPR2 | |
| SCHEMBL16438180 | 0.83 | TP53 (0.50) | TP53SLC7A5FPR1FPR2SLC1A3 | |
| SCHEMBL66413 | 0.83 | TP53 (0.50) | TP53SLC7A5FPR1FPR2SLC1A3 | |
| SCHEMBL659817 | 0.83 | TP53 (0.50) | TP53SLC7A5FPR1FPR2SLC1A3 | |
| SCHEMBL24287053 | 0.82 | TP53 (0.38) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL14792993 | 0.80 | TP53 (0.36) | TP53SLC7A5FPR1FPR2 | |
| Water SCHEMBL8870694 | 0.80 | TP53 (0.47) | TP53SLC7A5FPR1FPR2SLC1A3 | |
| SCHEMBL2538284 | 0.79 | TP53 (0.40) | TP53SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239828-A1 | MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4194428-A1 | HYDROCOLLOID PARTICLE SUSPENSION USEFUL AS RHEOLOGICAL MODIFIER FOR CEMENTITIOUS APPLICATIONS, USE OF A HYDROCOLLOID PARTICLE SUSPENSION | Construction Research & Technology GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-9120900-B2 | Polymer-bound bisacylphosphine oxides | BASF SE (DE) | 2015-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239828-A1 | MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS | M6PR, ASGR1, IGF2R | TP53 3465/4885SLC7A5 1587/4885FPR1 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.